Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• المؤلفون الرئيسيون: Min-Lan Tsai (مؤلف), Hsiu-Chen Lin (مؤلف), Chiung-Hui Yen (مؤلف), Jung-Tzu Ku (مؤلف), Shian-Ying Sung (مؤلف), Hsi Chang (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2022-10-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...